SCHEMBL3402785

SCHEMBL3402785

NC(=O)C1CCCN(C(=O)CO)C1

nearest known ligand 0.56

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.56
MAPK1 P28482 1/20 0.56
LMNA P02545 3/20 0.55
HSD17B10 Q99714 2/20 0.50
GLA P06280 1/20 0.50
KMT2A Q03164 3/20 0.47
BCHE P06276 1/20 0.45
MEN1 O00255 2/20 0.44
GAA P10253 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
KDM4E B2RXH2 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14949540 0.89 GAA (0.47) ALDH1A1MAPK1LMNAGAASMN1; SMN2
SCHEMBL3399181 0.84 ALDH1A1 (0.63) ALDH1A1MAPK1LMNAHSD17B10GLA
SCHEMBL22481549 0.84 ALDH1A1 (0.60) ALDH1A1MAPK1LMNAHSD17B10GLA
SCHEMBL4002663 0.84 ALDH1A1 (0.48) ALDH1A1MAPK1LMNAKMT2AMEN1
SCHEMBL14009856 0.84 ALDH1A1 (0.51) ALDH1A1MAPK1LMNAKMT2AMEN1
SCHEMBL14949558 0.83 ALDH1A1 (0.55) ALDH1A1MAPK1LMNAHSD17B10GLA
SCHEMBL7362051 0.81 ALDH1A1 (0.58) ALDH1A1MAPK1LMNAHSD17B10GLA
SCHEMBL1595209 0.81 ALDH1A1 (0.58) ALDH1A1MAPK1LMNAHSD17B10GLA
SCHEMBL25363482 0.79 ALDH1A1 (0.57) ALDH1A1MAPK1LMNAHSD17B10GLA
SCHEMBL2224391 0.79 ALDH1A1 (0.57) ALDH1A1MAPK1LMNAHSD17B10GLA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025058459-A1 NOVEL IMIDAZOPYRIDINE-BASED COMPOUND AND COMPOSITION COMPRISING SAME AS ACTIVE INGREDIENT FOR PREVENTING, ALLEVIATING, OR TREATING GASTROINTESTINAL INFLAMMATORY DISEASES OR GASTRIC ACID-RELATED DISEASES (주)휴온스 2025-03-20 WO claimed
US-8445501-B2 Substituted 7-carboxamido-pyrrolo[3,2-d]pyrimidines TAKEDA GMBH (DE) 2013-05-21 US claimed
WO-2025058459-A1 NOVEL IMIDAZOPYRIDINE-BASED COMPOUND AND COMPOSITION COMPRISING SAME AS ACTIVE INGREDIENT FOR PREVENTING, ALLEVIATING, OR TREATING GASTROINTESTINAL INFLAMMATORY DISEASES OR GASTRIC ACID-RELATED DISEASES (주)휴온스 2025-03-20 WO disclosed
US-8445501-B2 Substituted 7-carboxamido-pyrrolo[3,2-d]pyrimidines TAKEDA GMBH (DE) 2013-05-21 US disclosed
EP-2247594-A1 PYRROLOPYRIMIDINECARBOXAMIDES Nycomed GmbH (DE) 2010-11-10 EP disclosed
WO-2009106531-A1 PYRROLOPYRIMIDINECARBOXAMIDES NYCOMED GMBH (DE) 2009-09-03 WO disclosed